Repository logo

Browsing by Author "Vieira, L"

Now showing 1 - 3 of 3
  • Alcaptonúria: relato de caso
    Publication . Coutinho, I; Rivera-Monge, D; Portela, R; Vieira, L; Freitas, D
    Introdução: A alcaptonúria é uma doença rara do metabolismo da fenilalanina e tirosina. As manifestações oculares desta doença são comuns, afectam várias estruturas oculares e podem auxiliar no diagnóstico da doença. Métodos: Descrição clínica de um doente com alcaptonúria Resultados: Homem 70 anos, que recorreu ao serviço de urgência por queixa de baixa acuidade visual progressiva. Apresentava lesões hiperpigmentadas na conjuntiva, esclera e córnea perilímbica e pressão intraocular elevada. Como antecedentes pessoais referia o diagnóstico de artropatia ocronótica, litíase renal e lesões hiperpigmentadas na pele. Estabeleceu-se o diagnóstico de alcaptonúria e glaucoma secundário. Conclusōes:. Várias estruturas oculares são afectadas, sendo a hiperpigmentação da esclera, sobretudo na área interpalpebral, a principal manifestação ocular e a deposição de pigmento em “oil drop” na córnea perilímbica considerada patognomónica da doença. É fundamental conhecer esta patologia, seus achados clínicos e tê-la em consideração no diagnóstico diferencial de hiperpigmentação das estruturas oculares.
    2016Conference object Open access Show more
  • Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia
    Publication . Silva, M; Vargas, S; Coelho, A; Ferreira, E; Mendonça, J; Vieira, L; Maia, R; Dias, A; Ferreira, T, et al.
    We investigated biomarkers and genetic modulators of the cerebral vasculopathy (CV) subphenotype in pediatric sickle cell anemia (SCA) patients of sub-Saharan African ancestry. We found that one VCAM1 promoter haplotype (haplotype 7) and VCAM1 single nucleotide variant rs1409419_T were associated with stroke events, stroke risk, as measured by time-averaged mean of maximum velocity in the middle cerebral artery, and with high serum levels of the hemolysis biomarker lactate dehydrogenase. Furthermore, VCAM-1 ligand coding gene ITGA4 variants rs113276800_A and rs3770138_T showed a positive association with stroke events. An additional positive relationship between a genetic variant and stroke risk was observed for ENPP1 rs1044498_A. Conversely, NOS3 variants were negatively associated with silent cerebral infarct events (VNTR 4b_allele and haplotype V) and CV globally (haplotype VII). The -alpha3.7kb-thal deletion did not show association with CV. However, it was associated with higher red blood cell and neutrophil counts, and lower mean corpuscular volume, mean corpuscular hemoglobin and red cell distribution width. Our results underline the importance of genetic modulators of the CV sub-phenotype and their potential as SCA therapeutic targets. We also propose that a biomarker panel comprising biochemical, hematological, imaging and genetic data would be instrumental for CV prediction, and prevention.
    2020Journal article Restricted access Show more
  • Genetic Background and Expression of the New qepA4 Gene Variant Recovered in Clinical TEM-1- and CMY-2-Producing Escherichia coli.
    Publication . Manageiro, V; Félix, D; Jones-Dias, D; Sampaio, D; Vieira, L; Sancho, L; Ferreira, E; Caniça, M
    A new QepA4 variant was detected in an O86:H28 ST156-fimH38 Escherichia coli, showing a multidrug-resistance phenotype. PAβN inhibition of qepA4-harboring transconjugant resulted in increase of nalidixic acid accumulation. The qepA4 and catA1 genes were clustered in a 26.0-kp contig matching an IncF-type plasmid, and containing a Tn21-type transposon with multiple mobile genetic elements. This QepA variant is worrisome because these determinants might facilitate the selection of higher-level resistance mutants, playing a role in the development of resistance, and/or confer higher-level resistance to fluoroquinolones in association with chromosomal mutations.
    2017Journal article Open access Show more